STABLE EXPRESSION OF TRANSFECTED HUMAN INVOLUCRIN GENE IN VARIOUS CELL-TYPES - EVIDENCE FOR INSITU CROSS-LINKING BY TYPE-I AND TYPE-II TRANSGLUTAMINASE

被引:17
|
作者
RORKE, EA
ECKERT, RL
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,DEPT DERMATOL,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106
[3] CASE WESTERN RESERVE UNIV,SCH MED,DEPT REPROD BIOL,CLEVELAND,OH 44106
[4] CASE WESTERN RESERVE UNIV,SCH MED,DEPT ENVIRONM HLTH SCI,CLEVELAND,OH 44106
关键词
D O I
10.1111/1523-1747.ep12481579
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Involucrin is a 68-kd precursor of the cornified envelope in keratinocytes. During terminal differentiation, involucrin becomes covalently cross-linked to other proteins by a membrane-anchored calcium-activated transglutaminase (TG) to form part of the cornified envelope. To better understand this process, we have used vector-mediated gene transfer to express human involucrin in a variety of cell types. Authentic involucrin protein was expressed in Chinese hamster ovarian (CHO) cells (fibroblasts), PtK2 rat kangaroo kidney cells (simple epithelial), and rat epidermal keratinocytes (stratifying squamous epithelial). The expression vector included an independent transcription unit encoding the aminoglycoside phosphotransferase gene (neo-r) allowing selection of stable involucrin-positive, G418-resistant clonal cell lines. In each cell type, involucrin levels were comparable to the endogenous expression observed in SCC-13 cells. Immunofluorescence localization studies revealed a uniform involucrin distribution throughout the cytoplasm in each cell type. Elevation of intracellular calcium resulted in cross-linking of involucrin in both CHO cells and rat keratinocytes, a process that was inhibited by EDTA and cystamine. In contrast, no cross-linking was observed in PtK2 cells or long-term passaged rat keratinocytes. Transglutaminase assays showed that rat keratinocytes contain predominantly a particulate (type I) form, whereas CHO cells contain only soluble TG (type II). PtK2 cells and long-term passaged keratinocytes, which were unable to cross-link involucrin, contained barely detectable TG activity. These results indicate 1) that involucrin is an efficient in situ substrate for both type I and type II transglutaminase and 2) that involucrin cross-linking is strictly TG dependent.
引用
收藏
页码:543 / 548
页数:6
相关论文
共 50 条
  • [41] EVALUATION OF AN IMMUNOBLOT ASSAY FOR SEROLOGICAL CONFIRMATION AND DIFFERENTIATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II
    ROBERTS, BD
    FOUNG, SKH
    LIPKA, JJ
    KAPLAN, JE
    HADLOCK, KG
    REYES, GR
    CHAN, L
    HENEINE, W
    KHABBAZ, RF
    JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (02) : 260 - 264
  • [42] EVALUATION OF AN IMMUNOBLOT ASSAY FOR SEROLOGICAL CONFIRMATION AND DIFFERENTIATION OF HUMAN T-CELL LYMPHOTROPHIC VIRUS TYPE-I AND TYPE-II
    ROBERTS, BD
    FOUNG, SKH
    LIPKA, JJ
    KAPLAN, JE
    HADLOCK, KG
    REYES, GR
    CHAN, L
    HENEINE, W
    KHABBAZ, RF
    TRANSFUSION, 1992, 32 (08) : S58 - S58
  • [43] EXPRESSION OF GM1-GANGLIOSIDOSIS TYPES-I AND TYPE-II IN FIBROBLAST CELL CULTURE
    CALLAHAN, J
    PINSKY, L
    POWELL, E
    WOLFE, LS
    PEDIATRIC RESEARCH, 1970, 4 (05) : 438 - &
  • [44] Increased fetal lung expansion changes the proportion of alveolar epithelial cells (AEC); Evidence for type-II to type-I cell differentiation
    Hooper, SB
    Flecknoe, S
    Maritz, G
    Harding, R
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A669 - A669
  • [45] LOCALIZATION OF THE EXPRESSION OF TYPE-I, TYPE-II, TYPE-III COLLAGEN, AND AGGRECAN CORE PROTEIN GENES IN DEVELOPING HUMAN ARTICULAR-CARTILAGE
    TREILLEUX, I
    MALLEINGERIN, F
    LEGUELLEC, D
    HERBAGE, D
    MATRIX, 1992, 12 (03): : 221 - 232
  • [46] ESTABLISHMENT OF NOVEL LYMPHOID-CELL LINES DUALLY INFECTED WITH HUMAN T-CELL LYMPHOTROPIC VIRUSES TYPE-I AND TYPE-II
    KUBOTA, T
    MORISHITA, N
    TANAKA, Y
    SAWADA, T
    MIYAGI, T
    OHTSUKI, Y
    MIYOSHI, I
    JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01): : 220 - 224
  • [47] NO EVIDENCE FOR HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I OR HUMAN T-CELL LEUKEMIA-VIRUS TYPE-II INFECTION IN PATIENTS WITH MULTIPLE-SCLEROSIS
    PERL, A
    NAGY, K
    PAZMANY, T
    ISAACS, C
    BARACZKA, K
    SZABO, T
    FEHER, J
    ARCHIVES OF NEUROLOGY, 1990, 47 (10) : 1061 - 1063
  • [48] TYPE-SPECIFIC IMMUNE-RESPONSE TO HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV) TYPE-I AND TYPE-II INFECTIONS IN NIGERIA
    OLALEYE, DO
    BERNSTEIN, L
    SHENG, ZJ
    EKWEOZOR, CC
    LI, XY
    SULLIVANHALLEY, J
    RASHEED, S
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 50 (04): : 479 - 486
  • [49] SEGREGATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I AND TYPE-II INFECTIONS BY ANTIBODY REACTIVITY TO UNIQUE VIRAL EPITOPES
    LIPKA, JJ
    MIYOSHI, I
    HADLOCK, KG
    REYES, GR
    CHOW, TP
    BLATTNER, WA
    SHAW, GM
    HANSON, CV
    GALLO, D
    CHAN, L
    FOUNG, SKH
    JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (02): : 268 - 272
  • [50] COMPARISON OF THE TRANSACTIVATION CAPABILITIES OF THE HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I AND TYPE-II CHI-PROTEINS
    SHAH, NP
    WACHSMAN, W
    CANN, AJ
    SOUZA, L
    SLAMON, DJ
    CHEN, ISY
    MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (11) : 3626 - 3631